Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. FluxxLab LLC
WARNING LETTER
•FluxxLab LLC•August 4, 2022

FluxxLab LLC – FDA Warning Letter, Aug 4, 2022

Record Details

On August 4, 2022, the FDA and FTC issued a Warning Letter to FluxxLab LLC and Arendis, LLC, specifically addressing Arend John Kuijvenhoven, regarding the sale of unapproved and misbranded products related to COVID-19. The FDA reviewed the website fluxxlab.com on July 12, 2022, and August 1, 2022, identifying "Covid-19 Immune Support Tincture" and "CBDA+CBD Oil Tincture" products.

These products are marketed with claims to mitigate, prevent, treat, diagnose, or cure COVID-19, rendering them unapproved new drugs under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)).

Examples of violative claims include statements about CBDA binding to SARS-CoV-2 spike proteins to prevent infection, found on product pages like "https://fluxxlab.com/product-category/cbda/" and "https://fluxxlab.com/product/

Company
FluxxLab LLC
Inspection date
August 4, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Carolyn E. Becker
  • Serena Viswanathan (Associate Director)
View Company Profile

ID · 103ef140-381a-48cd-a9ff-b82a862afe53

Violation Codes4
21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 331(d)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore FluxxLab LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.